Spring Financial Update reveals slightly smaller deficit than projected Tis the season to protect yourself from Hantavirus Saskatoon's Mayor says they're hoping for little snow in the beginning of next winter First a Prince Albert business was shot at followed immediately by being set on fire

Saskatoon biomedical company signs letter of intent in reverse takeover

By Steve Chisholm May 31, 2022 | 8:32 AM

A Saskatoon-based company which focuses on developing a commercializing medical cannabinoid products has begun the legal process for a reverse takeover of Phoenix Canada Oil Company.

ZYUS Life Sciences has signed a non-binding Letter of Intent with Phoenix which outlines the terms of combining the businesses together. It would mean ZYUS would become a wholly-owned subsidiary of Phoenix. which is an investment management company based in Ontario.

Charlotte Moore Hepburn, the CEO of Phoenix, says there is a need for regulated medications to address adult pain which don’t contain opioids and she believes with ZYUS, Phoenix has found a strategic partner with “an impressive scientific and patent portfolio and program of research” with great biomedical potential.